Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Magnus Gisslen

Professor/ chief physician

Magnus Gisslen
Professor/ chief physician
magnus.gisslen@infect.gu.se

Postal Address: Su sahlgrenska, 41345 Göteborg
Visiting Address: Östra sjukhuset , Göteborg


Department of Infectious Diseases at Institute of Biomedicine (More Information)
Box 440
405 30 Göteborg
0313421000
Fax: +46 31846113

Visiting Address: Medicinaregatan 3, plan 5 , 405 30 Göteborg

Latest publications

Anti-Human Immunodeficiency Virus Antibodies in the Cerebrospinal Fluid: Evidence of Early Treatment Impact on Central Nervous System Reservoir?
P. D. Burbelo, R. W. Price, Lars Hagberg, H. Hatano, S. Spudich et al.
Journal of Infectious Diseases, Journal article 2018
Journal article

Structural brain abnormalities in successfully treated HIV infection: associations with disease and cerebrospinal fluid biomarkers.
Rosan A Van Zoest, Jonathan Underwood, Davide De Francesco, Caroline A Sabin, James H Cole et al.
The Journal of infectious diseases, Journal article 2018
Journal article

Blood-Brain Barrier Disruption Is Initiated During Primary HIV Infection and Not Rapidly Altered by Antiretroviral Therapy.
Elham Rahimy, Fang-Yong Li, Lars Hagberg, Dietmar Fuchs, Kevin Robertson et al.
The Journal of infectious diseases, Journal article 2017
Journal article

Sensitive, Subtype Independent HIV-1 PCR Assays for Assessment of Residual Viremia and Total HIV-1 DNA
Tomas Mellberg, Jon Krabbe, Maria Buzon, Ulrika Noborg, Magnus Lindh et al.
International Journal of Virology and AIDS, Journal article 2017
Journal article

Effect of therapy switch on time to second-line antiretroviral treatment failure in HIV-infected patients
A. Haggblom, M. Santacatterina, U. Neogi, Magnus Gisslén, B. Hejdeman et al.
Plos One, Journal article 2017
Journal article

Recent increased identification and transmission of HIV-1 unique recombinant forms in Sweden
U. Neogi, A. B. Siddik, P. Kalaghatgi, Magnus Gisslén, G. Bratt et al.
Scientific Reports, Journal article 2017
Journal article

Showing 41 - 50 of 149

2014

An example of genetically distinct HIV-1 variants in cerebrospinal fluid and plasma during suppressive therapy.
Viktor Dahl, Magnus Gisslén, Lars Hagberg, Julia Peterson, Wei Shao et al.
The Journal of infectious diseases, Journal article 2014
Journal article

Temporal Trends in the Swedish HIV-1 Epidemic: Increase in Non-B Subtypes and Recombinant Forms over Three Decades.
Ujjwal Neogi, Amanda Häggblom, Michele Santacatterina, Göran Bratt, Magnus Gisslén et al.
PloS one, Journal article 2014
Journal article

Evolving Character of Chronic Central Nervous System HIV Infection
Richard W. Price, Serena S. Spudich, Julia Peterson, Sarah Joseph, Dietmar Fuchs et al.
Seminars in Neurology, Journal article 2014
Journal article

2013

Kinetics of Microbial Translocation Markers in Patients on Efavirenz or Lopinavir/r Based Antiretroviral Therapy
J. Vesterbacka, P. Nowak, B. Barqasho, S. Abdurahman, J. Nystrom et al.
PLoS ONE, Journal article 2013
Journal article

Approach to Cerebrospinal Fluid (CSF) Biomarker Discovery and Evaluation in HIV Infection.
Richard W Price, Julia Peterson, Dietmar Fuchs, Thomas E Angel, Henrik Zetterberg et al.
Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology, Journal article 2013
Journal article

Cerebrospinal Fluid and Neuroimaging Biomarker Abnormalities Suggest Early Neurological Injury in a Subset of Individuals During Primary HIV Infection.
Michael J Peluso, Dieter J Meyerhoff, Richard W Price, Julia Peterson, Evelyn Lee et al.
The Journal of infectious diseases, Journal article 2013
Journal article

Cerebrospinal fluid neopterin decay characteristics after initiation of antiretroviral therapy.
Aylin Yilmaz, Constantin T Yiannoutsos, Dietmar Fuchs, Richard W Price, Kathryn Crozier et al.
Journal of neuroinflammation, Journal article 2013
Journal article

Showing 41 - 50 of 149

Page Manager: Webmaster|Last update: 4/19/2017
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?